D
Biogen Inc. BIIB
$131.95 $3.953.09% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 634.80M 240.50M 266.70M 388.50M 583.60M
Total Depreciation and Amortization 194.30M 183.20M 184.00M 182.80M 158.90M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 121.40M 169.10M 281.90M 130.50M 71.90M
Change in Net Operating Assets -789.60M -333.50M 28.30M 233.80M -188.60M
Cash from Operations 160.90M 259.30M 760.90M 935.60M 625.80M
Capital Expenditure -26.60M -37.10M -39.30M -35.00M -33.50M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- 0.00 -1.07B --
Divestitures -- -- -- -- --
Other Investing Activities -30.40M -10.20M 20.70M -71.30M 500.00M
Cash from Investing -57.00M -47.30M -18.60M -1.18B 466.50M
Total Debt Issued 1.73B -- -- -- --
Total Debt Repaid -1.75B -- 0.00 0.00 -250.00M
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 4.90M -23.00M 7.90M -6.60M 4.80M
Cash from Financing -11.70M -23.00M 7.90M -6.60M -245.20M
Foreign Exchange rate Adjustments 68.30M 34.30M -74.40M 42.40M -12.60M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 160.50M 223.30M 675.80M -209.70M 834.50M